Uploaded May 2026 | Updated September 2026, 2 weeks ago
scitechdaily.com/fda-approved-seizure-drug-may-stop-alzheimers-before-it-starts
Animation shows what happens inside a neuron during the synaptic vesicle cycle and how administering levetiracetam enables APP to remain on the cell’s surface longer, diverting it away from the pathway that produces toxic amyloid‑beta 42 proteins.
Credit: Nalini Rao, Northwestern University
scitechdaily.com/fda-approved-seizure-drug-may-stop-alzheimers-before-it-starts
Animation shows what happens inside a neuron during the synaptic vesicle cycle and how administering levetiracetam enables APP to remain on the cell’s surface longer, diverting it away from the pathway that produces toxic amyloid‑beta 42 proteins.
Credit: Nalini Rao, Northwestern University
